Our Medical Advisory Board is made up of renowned Healthcare Professionals whose unique perspectives and expertise inform the strategic direction and success of the company.
Our Political Advisory Board comprises renowned political experts and healthcare professionals who provide strategic guidance and advice to support Sanity Group to meet its mission and objectives.
Leading German cannabis company Sanity Group announced today a $37.6M Series B financing round – Europe’s largest cannabis investment round to date. The funding round was led by BAT Group* with ongoing commitment from existing Sanity Group investors such as Redalpine and Casa Verde Capital and brings total funds raised by the company to over $100M.
Berlin-based Sanity Group has signed new, exclusive supply agreements for medical cannabis with partners from Portugal, South Africa and Canada, securing further exclusive rights to around 20 high-THC cannabis flos from selected cultivars with a minimum volume of three tons per year for the brands Vayamed and AVAAY Medical. Deliveries are already scheduled to start at the end of the third quarter and beginning of the fourth quarter of 2022. In addition, further important strategic partnerships have been signed.
Berlin-based health and life science company Sanity Group has expanded its management team around CEO Finn Hänsel: Dr. Konstantin Rutz is the new Managing Director of the Group’s Medical division, Laura Simonow is Managing Director of the Consumer divison Sanity Care. The management team has also been broadened at Group level.